Therapeutic Class
CureDuchenne talks solutions to fill gaps in the CGT space
Therapeutic ClassCureDuchenne talks solutions to fill gaps in the CGT spaceCureDuchenne talks solutions to fill gaps in the CGT space
BioProcess Insider sat down with Michael Kelly, CureDuchenne’s CSO to discuss gaps in the gene therapy space and the strategy to fill them.